1. Ershadi, S, Biba, U, Bensellam, N, Sanchez, K, Cheng, D, Gregoire, S et al.. Validating Optimal ICD-10 Classification Approaches for Identifying Perioral Dermatitis: A Retrospective Chart Review. J Am Acad Dermatol. 2025; :. doi: 10.1016/j.jaad.2025.04.061. PubMed PMID:40339810 .
  2. Gregoire, S, McIntosh, B, Sanchez, K, Biba, U, Mostaghimi, A. Local Corticosteroids for Alopecia Areata: A Narrative Review. Dermatol Ther (Heidelb). 2025; :. doi: 10.1007/s13555-025-01421-2. PubMed PMID:40323545 .
  3. Cheng, D, Gaurav, A, Xiang, D, Ji, H, Hirsh, DA, Chen, S et al.. Hormonal Intrauterine Devices Are Associated With Lower Long-Term Melasma Risk Compared to Combined and Progestin-Only Oral Contraceptives: a Population-Based Cohort Study. J Am Acad Dermatol. 2025; :. doi: 10.1016/j.jaad.2025.04.040. PubMed PMID:40286818 .
  4. Mostaghimi, A, Gibson, A, Dwyer, G, Oluboyede, Y, Mazar, I, Gorbatenko-Roth, K et al.. Exploring Factors That Influence the Measurement of Patient-Reported Impacts of Alopecia Areata. Dermatol Ther (Heidelb). 2025; :. doi: 10.1007/s13555-025-01400-7. PubMed PMID:40261547 .
  5. Mostaghimi, Y, Haddadi, M, Hojjati, Z. lncRNA PAN3-AS1 Modulates Cilium Assemble Signaling Pathway Through Regulation of RPGR as a Potential MS Diagnostic Biomarker: Integrated Systems Biology Investigation. J Mol Neurosci. 2025;75 (2):49. doi: 10.1007/s12031-025-02331-w. PubMed PMID:40227518 .
  6. King, B, Mostaghimi, A, Shimomura, Y, Piraccini, BM, Blume-Peytavi, U, Sontag, A et al.. Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment. Am J Clin Dermatol. 2025; :. doi: 10.1007/s40257-025-00932-0. PubMed PMID:40214720 .
  7. Gordon, KB, Tada, Y, Anadkat, MJ, Choon, SE, Elewski, B, Barker, JN et al.. Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions. Dermatol Ther (Heidelb). 2025; :. doi: 10.1007/s13555-025-01372-8. PubMed PMID:40186034 .
  8. Mostaghimi, A, Craiglow, B, King, B, Shapiro, J, Ko, J, Tosti, A et al.. Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib. Br J Dermatol. 2025; :. doi: 10.1093/bjd/ljaf088. PubMed PMID:40179237 .
  9. Tobey, T, Ortega-Loayza, AG, Choe, SI, Haddadin, O, Bardazzi, F, Croitoru, DO et al.. Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum. Arch Dermatol Res. 2025;317 (1):449. doi: 10.1007/s00403-025-03920-w. PubMed PMID:39979653 .
  10. Coppinger, AJ, Wambier, CG. Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., "Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata". J Am Acad Dermatol. 2025; :. doi: 10.1016/j.jaad.2024.11.086. PubMed PMID:39971243 .
  11. Choe, J, Yan, A, Gaurav, A, Xia, E, Bensellam, N, Sahni, DR et al.. Evaluation of DLQI and Skindex-16 for assessing quality of life in patients with cellulitis. Arch Dermatol Res. 2025;317 (1):432. doi: 10.1007/s00403-025-03948-y. PubMed PMID:39964552 .
  12. Ly, S, Manjaly, P, Kamal, K, Mostaghimi, A. Trends in Medicare Part D spending on topical steroids from 2012 to 2021: Increasing costs of generic topical steroids and potential savings. J Am Acad Dermatol. 2025; :. doi: 10.1016/j.jaad.2025.02.025. PubMed PMID:39955002 .
  13. Gordon, KB, Tada, Y, Anadkat, MJ, Choon, SE, Elewski, B, Barker, JN et al.. Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions. Dermatol Ther (Heidelb). 2025;15 (2):395-411. doi: 10.1007/s13555-024-01325-7. PubMed PMID:39928095 PubMed Central PMC11832866.
  14. Barker, JN, Casanova, E, Choon, SE, Foley, P, Fujita, H, Gonzalez, C et al.. Global Delphi consensus on treatment goals for generalized pustular psoriasis. Br J Dermatol. 2025;192 (4):706-716. doi: 10.1093/bjd/ljae491. PubMed PMID:39844356 .
  15. Gaurav, A, Xia, E, Stein, D, Noe, MH, Mostaghimi, A, Imadojemu, SE et al.. Epidemiology of cutaneous sarcoidosis in an electronic health database: a cross-sectional analysis. Arch Dermatol Res. 2025;317 (1):226. doi: 10.1007/s00403-024-03726-2. PubMed PMID:39792156 .
  16. Westmeijer, M, Ebriani, J, Thompson, BB, Holt, A, Brumbaugh, B, Ma, KS et al.. External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Dermatol. 2025;64 (5):952-953. doi: 10.1111/ijd.17584. PubMed PMID:39592838 .
  17. Mostaghimi, A, Augustin, M, Harada, K, Senna, M, Dutronc, Y, Yu, G et al.. Continued treatment with baricitinib results in meaningful scalp responses among scalp non-responder patients with eyebrow/eyelash regrowth in the first year. J Eur Acad Dermatol Venereol. 2024; :. doi: 10.1111/jdv.20334. PubMed PMID:39569884 .
  18. Akiska, YM, Mirmirani, P, Roseborough, I, Mathes, E, Bhutani, T, Ambrosy, A et al.. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement. JAMA Dermatol. 2025;161 (1):87-95. doi: 10.1001/jamadermatol.2024.4593. PubMed PMID:39565602 .
  19. Choe, J, Yan, A, Charrow, A, Mostaghimi, A, Shiboski, S, Chang, AY et al.. Correction to: Limited English proficiency is associated with access barriers to isotretinoin for acne. Arch Dermatol Res. 2024;317 (1):11. doi: 10.1007/s00403-024-03459-2. PubMed PMID:39520574 .
  20. Xia, E, Kam, L, Mostaghimi, A. Trends in Phototherapy Utilization, Payments, and Geographic Distribution: An Analysis of United States Medicare Part B From 2000 to 2021. Photodermatol Photoimmunol Photomed. 2024;40 (6):e13008. doi: 10.1111/phpp.13008. PubMed PMID:39455430 .
  21. Craiglow, B, Lee, YW, Vañó-Galván, S, Egeberg, A, Dutronc, Y, Durand, F et al.. Publisher Correction: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatol Ther (Heidelb). 2024;14 (11):3193. doi: 10.1007/s13555-024-01265-2. PubMed PMID:39404927 PubMed Central PMC11557806.
  22. Schneeweiss, MC, Glynn, RJ, Wyss, R, Anand, P, Jin, Y, Landon, J et al.. A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System. J Invest Dermatol. 2025;145 (5):1070-1080. doi: 10.1016/j.jid.2024.08.034. PubMed PMID:39362623 PubMed Central PMC11958787.
  23. Mostaghimi, D, Mehta, S, Yoon, J, Kosana, P, Marra, CM, Corley, MJ et al.. Epigenetic Changes in Cerebrospinal Fluid and Blood of People With Neurosyphilis. J Infect Dis. 2025;231 (4):883-893. doi: 10.1093/infdis/jiae476. PubMed PMID:39356164 PubMed Central PMC11998562.
  24. Eltayeb, S, Carroll, LL, Dippel, L, Mostaghimi, M, Riedel, W, Moskaleva, LV et al.. Selective Oxidation of Methanol to Methyl Formate on Gold: The Role of Low-Coordinated Sites Revealed by Isothermal Pulsed Molecular Beam Experiments and AIMD Simulations. J Phys Chem C Nanomater Interfaces. 2024;128 (36):14978-14988. doi: 10.1021/acs.jpcc.4c03959. PubMed PMID:39291271 PubMed Central PMC11403654.
  25. Choe, J, Gaurav, A, Xia, E, Yan, A, Mostaghimi, A, Barbieri, JS et al.. Use and cost of dietary changes, supplements, over-the-counter topicals, and prescriptions for acne: a cross-sectional survey among United States adults. Arch Dermatol Res. 2024;316 (8):598. doi: 10.1007/s00403-024-03349-7. PubMed PMID:39225715 .
  26. Xia, E, Manjaly, P, Ly, S, Kamal, K, Theodosakis, N, Mostaghimi, A et al.. Disproportionality analysis of psychiatric morbidities associated with isotretinoin using VigiBase. Arch Dermatol Res. 2024;316 (8):567. doi: 10.1007/s00403-024-03293-6. PubMed PMID:39180584 .
  27. Mostaghimi, A, Soliman, AM, Li, C, Barqawi, YK, Grada, A. Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata. JAMA Dermatol. 2024;160 (9):945-952. doi: 10.1001/jamadermatol.2024.2404. PubMed PMID:39083282 PubMed Central PMC11292571.
  28. Needham, M, Pichardo, R, Alavi, A, Chang, AY, Daveluy, S, DeNiro, KL et al.. Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study. Cutis. 2024;113 (6):251-254. doi: 10.12788/cutis.1027. PubMed PMID:39082985 .
  29. Shah, PN, Romar, GA, Manukyan, A, Ko, WC, Hsieh, PC, Velasquez, GA et al.. Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets. J Clin Invest. 2024;134 (17):. doi: 10.1172/JCI178253. PubMed PMID:39042477 PubMed Central PMC11364394.
  30. Choe, J, Yan, A, Charrow, A, Mostaghimi, A, Shiboski, S, Chang, AY et al.. Limited English proficiency is associated with access barriers to isotretinoin for acne. Arch Dermatol Res. 2024;316 (7):464. doi: 10.1007/s00403-024-03208-5. PubMed PMID:38990267 .
  31. Rahimipour Anaraki, S, Mohammadian, A, Mostaghimi, T, Sadeghi, F, Akbari, R. SARS-CoV-2 PCR cycle threshold value at admission might not be a good predictor of in-hospital COVID-19-associated AKI. J Gen Fam Med. 2024;25 (4):179-186. doi: 10.1002/jgf2.682. PubMed PMID:38966657 PubMed Central PMC11221053.
  32. Sparks, R, Rachmaninoff, N, Lau, WW, Hirsch, DC, Bansal, N, Martins, AJ et al.. A unified metric of human immune health. Nat Med. 2024;30 (9):2461-2472. doi: 10.1038/s41591-024-03092-6. PubMed PMID:38961223 .
  33. Kamal, K, Xiang, D, Young, K, Fisher, DE, Mostaghimi, A, Theodosakis, N et al.. Association Between Natural Hair Color, Race, and Alopecia. Dermatol Ther (Heidelb). 2024;14 (8):2109-2117. doi: 10.1007/s13555-024-01218-9. PubMed PMID:38954383 PubMed Central PMC11333427.
  34. Craiglow, B, Lee, YW, Vañó-Galván, S, Egeberg, A, Dutronc, Y, Durand, F et al.. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib. Dermatol Ther (Heidelb). 2024;14 (7):1959-1968. doi: 10.1007/s13555-024-01208-x. PubMed PMID:38904749 PubMed Central PMC11265044.
  35. Mostaghimi, A, Ko, J, Tosti, A, McMichael, A, Ohyama, M, Ito, T et al.. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies. J Am Acad Dermatol. 2024;91 (4):729-732. doi: 10.1016/j.jaad.2024.05.077. PubMed PMID:38852742 .
  36. Manjaly, P, Kamal, K, Ly, S, Sanchez, K, Getachew, E, Mostaghimi, A et al.. Disparities in State Medicaid Coverage of Tretinoin for Pigmentary Disorders Compared to Acne Vulgaris. J Drugs Dermatol. 2024;23 (6):e151-e153. doi: 10.36849/JDD.8069. PubMed PMID:38834215 .
  37. Yan, A, Drake, L, Hadsall, S, Gaurav, A, Xia, E, Mostaghimi, A et al.. Evaluating the sources and types of dietary and nutritional advice for patients with alopecia areata. Arch Dermatol Res. 2024;316 (6):283. doi: 10.1007/s00403-024-02940-2. PubMed PMID:38796551 .
  38. Ziad, A, Al-Zubi, L, Santiago-Soltero, K, Li, YH, Huang, KP, Scott, DA et al.. Hair loss and quality of life in muslim American women. Arch Dermatol Res. 2024;316 (6):257. doi: 10.1007/s00403-024-02950-0. PubMed PMID:38795172 .
  39. Guo, X, Lin, CY, Alavi, S, You, L, Mostaghimi, J. Investigation of calcium variations in single cells and the impact of Yoda1 on osteocytes by ICP-OES. Anal Chim Acta. 2023;1281 :341906. doi: 10.1016/j.aca.2023.341906. PubMed PMID:38783744 .
  40. Eltayeb, S, Carroll, LL, Dippel, L, Mostaghimi, M, Riedel, W, Moskaleva, LV et al.. Partial Oxidation of Methanol on Gold: How Selectivity Is Steered by Low-Coordinated Sites. ACS Catal. 2024;14 (10):7901-7906. doi: 10.1021/acscatal.3c04578. PubMed PMID:38779185 PubMed Central PMC11106737.
  41. Getachew, ED, Kamal, K, Young, K, Xiang, DH, Semenov, Y, Mostaghimi, A et al.. Racial and ethnic differences in melasma treatment patterns: a multi-institution study. Arch Dermatol Res. 2024;316 (5):175. doi: 10.1007/s00403-024-02974-6. PubMed PMID:38758256 .
  42. Getachew, ED, Kamal, K, Young, K, Xiang, DH, Semenov, Y, Mostaghimi, A et al.. A case-control study of racial differences in melasma risk factors and incidence in a diverse national United States population. J Am Acad Dermatol. 2024;91 (3):539-541. doi: 10.1016/j.jaad.2024.04.068. PubMed PMID:38729433 .
  43. Sadeghi, F, Mostaghimi, T, Taheri, M, Yazdani, S, Javadian, M, Ranaee, M et al.. Investigating the role of Epstein-Barr virus and human papillomavirus types 16 and 18 co-infections in cervical disease of Iranian women. Front Oncol. 2024;14 :1331862. doi: 10.3389/fonc.2024.1331862. PubMed PMID:38720799 PubMed Central PMC11076674.
  44. Kam, L, Xia, E, Mostaghimi, A. Home UVB phototherapy utilization among United States Medicare beneficiaries from 2000 to 2021. Photodermatol Photoimmunol Photomed. 2024;40 (3):e12971. doi: 10.1111/phpp.12971. PubMed PMID:38654591 .
  45. Tan, AJ, Archila, M, Barbieri, JS, Mostaghimi, A, Scherer, AM, Perez-Chada, LM et al.. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study. Arch Dermatol Res. 2024;316 (5):125. doi: 10.1007/s00403-024-02862-z. PubMed PMID:38637431 PubMed Central PMC11296352.
  46. Schneeweiss, MC, Mostaghimi, A, Chiuve, S, Schneeweiss, S, Anand, P, Schoder, K et al.. Validation of alopecia coding in US claims data among women of childbearing age. Pharmacoepidemiol Drug Saf. 2024;33 (4):e5782. doi: 10.1002/pds.5782. PubMed PMID:38566351 .
  47. Xia, E, Gaurav, A, Noe, MH, Mostaghimi, A, Imadojemu, SE. Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: A Cross-Sectional Analysis. J Invest Dermatol. 2024;144 (10):2308-2310.e2. doi: 10.1016/j.jid.2024.02.031. PubMed PMID:38548257 .
  48. Li, DG, Mostaghimi, A. The Quest for a More Accurate Diagnosis of Cellulitis: In Dreams Begin Responsibilities. JAMA Dermatol. 2024;160 (5):489-491. doi: 10.1001/jamadermatol.2024.0089. PubMed PMID:38536169 .
  49. Wang, YD, Kearney, LM, Blunt, MJ, Sun, C, Tang, K, Mostaghimi, P et al.. In situ characterization of heterogeneous surface wetting in porous materials. Adv Colloid Interface Sci. 2024;326 :103122. doi: 10.1016/j.cis.2024.103122. PubMed PMID:38513432 .
  50. Becker, SL, Rios-Duarte, JA, Morrison, GM, Xia, E, Mostaghimi, A, Himed, S et al.. Perioperative management and clinical outcomes of peristomal pyoderma gangrenosum. Arch Dermatol Res. 2024;316 (4):98. doi: 10.1007/s00403-024-02826-3. PubMed PMID:38446235 .
  51. Kamal, K, Manjaly, P, Ly, S, Zhou, G, Theodosakis, N, Mostaghimi, A et al.. Characterizing differences in outpatient dermatologic care utilization among disaggregated Asian American subgroups. Arch Dermatol Res. 2024;316 (3):95. doi: 10.1007/s00403-024-02832-5. PubMed PMID:38427050 .
  52. Manjaly, P, Sanchez, K, Gregoire, S, Ly, S, Kamal, K, Mostaghimi, A et al.. Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus. Dermatol Clin. 2024;42 (2):307-315. doi: 10.1016/j.det.2023.08.010. PubMed PMID:38423689 .
  53. Senna, M, Mostaghimi, A, Ohyama, M, Sinclair, R, Dutronc, Y, Wu, WS et al.. Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2. J Eur Acad Dermatol Venereol. 2024;38 (3):583-593. doi: 10.1111/jdv.19665. PubMed PMID:38391212 .
  54. Schneeweiss, MC, Shay, D, Ly, S, Wyss, R, Schneeweiss, S, Glynn, RJ et al.. Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2024;160 (3):334-340. doi: 10.1001/jamadermatol.2023.5895. PubMed PMID:38294794 PubMed Central PMC10831628.
  55. Raymakers, AJN, Kesselheim, AS, Mostaghimi, A, Feldman, WB. Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa. JAMA Dermatol. 2024;160 (3):297-302. doi: 10.1001/jamadermatol.2023.5857. PubMed PMID:38294784 PubMed Central PMC10831624.
  56. Gaurav, A, Eang, B, Mostaghimi, A. Alopecia Areata. JAMA Dermatol. 2024;160 (3):372. doi: 10.1001/jamadermatol.2023.4661. PubMed PMID:38265795 .
  57. Kamal, K, Xiang, DH, Young, K, Mostaghimi, A, Barbieri, JS, Cohen, JM et al.. Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case-control study in the All of Us Research Program. Arch Dermatol Res. 2024;316 (2):79. doi: 10.1007/s00403-023-02803-2. PubMed PMID:38252292 .
  58. Deng, Z, Mostaghimi, AHB, Gong, M, Chen, N, Siahrostami, S, Wang, X et al.. Pd 4d Orbital Overlapping Modulation on Au@Pd Nanowires for Efficient H2O2 Production. J Am Chem Soc. 2024;146 (4):2816-2823. doi: 10.1021/jacs.3c13259. PubMed PMID:38230974 .
  59. Afzal, N, Archila, M, Barbieri, JS, Charrow, A, Mostaghimi, A, Chada, LP et al.. The Impact of Hidradenitis Suppurativa on Health Care Decision Making and Vaccines. Res Sq. 2023; :. doi: 10.21203/rs.3.rs-3778510/v1. PubMed PMID:38196608 PubMed Central PMC10775376.
  60. Shakshouk, H, deCampos-Stairiker, M, Kody, S, Stenzel, P, Xia, E, Mostaghimi, A et al.. Mortality and Autopsy Findings in Patients with Pyoderma Gangrenosum: A Multi-Institutional Series. Dermatology. 2024;240 (2):352-356. doi: 10.1159/000536145. PubMed PMID:38185115 .
  61. Rajashekar, N, Mostaghimi, D, Jiang, F, Sanchez, A. Pulmonary Infarction Due to Direct-acting Oral Anticoagulant Malabsorption. J Brown Hosp Med. 2024;3 (1):90274. doi: 10.56305/001c.90274. PubMed PMID:40027385 PubMed Central PMC11864386.
  62. Ly, S, Manjaly, P, Kamal, K, Theodosakis, N, Charrow, A, Mostaghimi, A et al.. Insurance coverage among the largest insurers per state for laser hair removal in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2024;90 (4):859-862. doi: 10.1016/j.jaad.2023.12.016. PubMed PMID:38128832 .
  63. Mostaghimi, M, Pacheco Hernandez, H, Jiang, Y, Wenzel, W, Heinke, L, Kozlowska, M et al.. On-off conduction photoswitching in modelled spiropyran-based metal-organic frameworks. Commun Chem. 2023;6 (1):275. doi: 10.1038/s42004-023-01072-4. PubMed PMID:38110545 PubMed Central PMC10728195.
  64. Kamal, K, Xia, E, Li, SJ, Alavi, A, Cogen, AL, Firooz, A et al.. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group. J Invest Dermatol. 2024;144 (6):1295-1300.e6. doi: 10.1016/j.jid.2023.12.006. PubMed PMID:38110114 .
  65. Ferreira, BR, Vulink, N, Mostaghimi, L, Jafferany, M, Balieva, F, Gieler, U et al.. Classification of psychodermatological disorders: Proposal of a new international classification. J Eur Acad Dermatol Venereol. 2024;38 (4):645-656. doi: 10.1111/jdv.19731. PubMed PMID:38084889 .
  66. Mostaghimi, T, Shirafkan, H, Nasrollahian, S, Fayyazi, A, Hatami, M, Rajabnia, M et al.. Worldwide prevalence of extended-spectrum β-lactamases-producing uropathogenic Escherichia coli isolates among kidney transplant patients: a systematic review and meta-analysis. Infez Med. 2023;31 (4):466-475. doi: 10.53854/liim-3104-5. PubMed PMID:38075425 PubMed Central PMC10705850.
  67. Shields, A, Nock, MR, Ly, S, Manjaly, P, Mostaghimi, A, Barbieri, JS et al.. Evaluation of Stigma Toward Individuals With Acne. JAMA Dermatol. 2024;160 (1):93-98. doi: 10.1001/jamadermatol.2023.4487. PubMed PMID:38055249 PubMed Central PMC10701660.
  68. Lee, K, Woodbury, MJ, Zundell, MP, Aguero, R, Yousif, J, Williams, SC et al.. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol. 2023;22 (12):1153-1159. doi: 10.36849/JDD.7615. PubMed PMID:38051841 .
  69. Nusbaum, KB, Boettler, M, Korman, AM, Alavi, A, Alloo, A, Dissemond, J et al.. Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement. Int J Dermatol. 2024;63 (2):e67-e69. doi: 10.1111/ijd.16952. PubMed PMID:38044552 .
  70. Mostaghimi, T, Bahadoran, E, Bakht, M, Taheri, S, Sadeghi, H, Babaei, A et al.. Role of lncRNAs in Helicobacter pylori and Epstein-Barr virus associated gastric cancers. Life Sci. 2024;336 :122316. doi: 10.1016/j.lfs.2023.122316. PubMed PMID:38035995 .
  71. Jing, Y, Kumaran, AU, Stimson, DHR, Mardon, K, Najdovski, L, Armstrong, RT et al.. Positron emission tomography dataset of [11C]carbon dioxide storage in coal for geo-sequestration application. Sci Data. 2023;10 (1):840. doi: 10.1038/s41597-023-02754-3. PubMed PMID:38030650 PubMed Central PMC10687076.
  72. Brüggen, MC, Walsh, S, Ameri, MM, Anasiewicz, N, Maverakis, E, French, LE et al.. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus. JAMA Dermatol. 2024;160 (1):37-44. doi: 10.1001/jamadermatol.2023.4450. PubMed PMID:37966824 PubMed Central PMC10652220.
  73. Young, K, Pagan, AD, Yoon, J, Getachew, E, Leung, B, Nguyen, N et al.. Seasonal Patterns in Tetracycline-Associated Hyperpigmentation Among Patients With Acne Vulgaris. J Drugs Dermatol. 2023;22 (11):e9-e11. doi: 10.36849/JDD.7409. PubMed PMID:37943268 .
  74. Drake, L, Li, SJ, Reyes-Hadsall, S, Lee, K, Huang, K, Mostaghimi, A et al.. Post-Traumatic Stress Disorder in Patients with Alopecia Areata: A Survey Study in the USA. Skin Appendage Disord. 2023;9 (5):342-345. doi: 10.1159/000530356. PubMed PMID:37900780 PubMed Central PMC10601895.
  75. Li, SJ, Xia, E, Drake, L, Erickson, K, Ortega-Loayza, AG, Mostaghimi, A et al.. Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review. Dermatology. 2024;240 (1):26-31. doi: 10.1159/000534750. PubMed PMID:37879301 .
  76. Shields, A, Ly, S, Wafae, B, Chang, YF, Manjaly, P, Archila, M et al.. Safety and Effectiveness of Oral Nutraceuticals for Treating Acne: A Systematic Review. JAMA Dermatol. 2023;159 (12):1373-1382. doi: 10.1001/jamadermatol.2023.3949. PubMed PMID:37878272 PubMed Central PMC11015159.
  77. Shields, A, Ly, S, Wafae, B, Chang, YF, Manjaly, P, Archila, M et al.. The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review. J Am Acad Dermatol. 2024;90 (3):612-615. doi: 10.1016/j.jaad.2023.10.037. PubMed PMID:37871802 PubMed Central PMC10922156.
  78. Weizman, OE, Luyten, S, Lu, P, Song, E, Qin, K, Mostaghimi, D et al.. Developing synthetic tools to decipher the tumor-immune interactome. Proc Natl Acad Sci U S A. 2023;120 (44):e2306632120. doi: 10.1073/pnas.2306632120. PubMed PMID:37871202 PubMed Central PMC10622925.
  79. Martinez, J, Manjaly, C, Manjaly, P, Ly, S, Zhou, G, Barbieri, J et al.. Janus Kinase Inhibitors and Adverse Events of Acne: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2023;159 (12):1339-1345. doi: 10.1001/jamadermatol.2023.3830. PubMed PMID:37851459 PubMed Central PMC10585588.
  80. Ly, S, Reyes-Hadsall, S, Drake, L, Zhou, G, Nelson, C, Barbieri, JS et al.. Public Perceptions, Factors, and Incentives Influencing Patient Willingness to Share Clinical Images for Artificial Intelligence-Based Healthcare Tools. Dermatol Ther (Heidelb). 2023;13 (11):2895-2902. doi: 10.1007/s13555-023-01031-w. PubMed PMID:37737327 PubMed Central PMC10613161.
  81. Lee, H, Huang, KP, Mostaghimi, A, Choudhry, NK. Treatment Patterns for Alopecia Areata in the US. JAMA Dermatol. 2023;159 (11):1253-1257. doi: 10.1001/jamadermatol.2023.3109. PubMed PMID:37728940 PubMed Central PMC10512165.
  82. Done, N, Bartolome, L, Swallow, E, Gao, W, Carley, C, Wang, T et al.. Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis. Acta Derm Venereol. 2023;103 :adv12445. doi: 10.2340/actadv.v103.12445. PubMed PMID:37622204 PubMed Central PMC10469222.
  83. Zhao, H, Larson, C, Schepergerdes, BJ, Diefendorf, CM, Ortega-Loayza, AG, Mostaghimi, A et al.. Hundreds of inconsistencies in the nomenclature of pyoderma gangrenosum: The need to harmonise terminology for phenotypes. Int Wound J. 2024;21 (1):e14357. doi: 10.1111/iwj.14357. PubMed PMID:37605455 PubMed Central PMC10781587.
  84. Gregoire, S, Mostaghimi, A. Effective counseling of patients with hair loss. J Am Acad Dermatol. 2023;89 (2S):S40-S42. doi: 10.1016/j.jaad.2023.03.059. PubMed PMID:37591566 .
  85. Li, SJ, Reyes-Hadsall, S, Drake, L, Huang, K, Mostaghimi, A. Experiencing Workplace Bullying in Patients with Alopecia Areata: A Cross-Sectional Survey Study. Skin Appendage Disord. 2023;9 (4):258-261. doi: 10.1159/000529924. PubMed PMID:37564694 PubMed Central PMC10410103.
  86. Wei, BM, Fox, LP, Kaffenberger, BH, Korman, AM, Micheletti, RG, Mostaghimi, A et al.. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2024;90 (5):885-908. doi: 10.1016/j.jaad.2023.02.072. PubMed PMID:37516359 .
  87. Wei, BM, Fox, LP, Kaffenberger, BH, Korman, AM, Micheletti, RG, Mostaghimi, A et al.. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. J Am Acad Dermatol. 2024;90 (5):911-926. doi: 10.1016/j.jaad.2023.02.073. PubMed PMID:37516356 .
  88. Ly, S, Manjaly, P, Kamal, K, Shields, A, Wafae, B, Afzal, N et al.. Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis. Am J Clin Dermatol. 2023;24 (6):875-893. doi: 10.1007/s40257-023-00805-4. PubMed PMID:37464249 .
  89. Zhao, H, Mostaghimi, A, Sisley, JM, Ortega-Loayza, AG. Multilesional pyoderma gangrenosum is associated with longer healing times and higher rates of underlying comorbidities: A single-center prospective registry study. JAAD Int. 2023;12 :133-135. doi: 10.1016/j.jdin.2023.05.009. PubMed PMID:37409315 PubMed Central PMC10319331.
  90. Mostaghimi, M, Majdinasab, M, Golmakani, MT, Hadian, M, Hosseini, SMH. Development and characterization of antimicrobial alginate hydrogel beads filled with cinnamon essential oil nanoemulsion. J Biomater Sci Polym Ed. 2023;34 (15):2144-2160. doi: 10.1080/09205063.2023.2230843. PubMed PMID:37382897 .
  91. Piraccini, BM, Ohyama, M, Craiglow, B, Bewley, A, Ding, Y, Chen, YF et al.. Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials. J Dermatolog Treat. 2023;34 (1):2227299. doi: 10.1080/09546634.2023.2227299. PubMed PMID:37381691 .
  92. Drake, L, Huang, K, Mostaghimi, A. Nutritional Supplements and Hair Loss-Limitations to the Interpretation of Clinical Studies Before Implementation in Clinical Practice-Reply. JAMA Dermatol. 2023;159 (8):893. doi: 10.1001/jamadermatol.2023.1762. PubMed PMID:37379006 .
  93. Rinderknecht, FA, Nambudiri, V, Lee, MS, LaChance, A, Mostaghimi, A. Expanding Wig Coverage under Medicare: Improving Access for Patients with Alopecia. J Clin Aesthet Dermatol. 2023;16 (6):52. . PubMed PMID:37361364 PubMed Central PMC10286881.
  94. Schneeweiss, MC, Merola, JF, Wyss, R, Silverberg, JI, Mostaghimi, A. Venous Thromboembolism in Patients With Bullous Pemphigoid. JAMA Dermatol. 2023;159 (7):750-756. doi: 10.1001/jamadermatol.2023.1461. PubMed PMID:37285147 PubMed Central PMC10248807.
  95. Waters, M, Dobry, A, Le, ST, Shinkai, K, Beachkofsky, TM, Davis, MDP et al.. Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise. JAMA Dermatol. 2023;159 (7):772-777. doi: 10.1001/jamadermatol.2023.1347. PubMed PMID:37256599 PubMed Central PMC10838134.
  96. Walls, AC, Faletsky, A, Chu, B, Micheletti, RG, Mostaghimi, A. Epidemiology and diagnostic classification of adults presenting with an initial episode of leukocytoclastic vasculitis: A multicenter review of 440 patients. J Am Acad Dermatol. 2023;89 (3):582-584. doi: 10.1016/j.jaad.2023.04.055. PubMed PMID:37150302 .
  97. Xia, E, Li, SJ, Drake, L, Reyes-Hadsall, S, Mita, C, Drucker, AM et al.. An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review. J Invest Dermatol. 2023;143 (7):1133-1137.e12. doi: 10.1016/j.jid.2023.02.020. PubMed PMID:37115113 .
  98. Kamal, K, Young, K, Ly, S, Manjaly, P, Xiang, DH, Zhou, G et al.. Investigating the association between gender minority identity and skin cancer prevalence: A cohort study in the United States All of Us research program. J Eur Acad Dermatol Venereol. 2023;37 (9):e1151-e1153. doi: 10.1111/jdv.19156. PubMed PMID:37114382 PubMed Central PMC10524765.
  99. Sparks, R, Rachmaninoff, N, Hirsch, DC, Bansal, N, Lau, WW, Martins, AJ et al.. Multiomics integration of 22 immune-mediated monogenic diseases reveals an emergent axis of human immune health. Res Sq. 2023; :. doi: 10.21203/rs.3.rs-2070975/v1. PubMed PMID:36993430 PubMed Central PMC10055521.
  100. Wang, K, Tao, G, Sun, Z, Wei, J, Liu, J, Taylor, J et al.. Fecal Keratin 8 Is a Noninvasive and Specific Marker for Intestinal Injury in Necrotizing Enterocolitis. J Immunol Res. 2023;2023 :5356646. doi: 10.1155/2023/5356646. PubMed PMID:36959922 PubMed Central PMC10030213.
  101. Drake, L, Han, J, Reyes-Hadsall, S, Mostaghimi, A, Huang, K. Assessing Patient's Values When Selecting Treatments for Alopecia Areata: A Cross-Sectional Survey Study. Skin Appendage Disord. 2023;9 (2):99-103. doi: 10.1159/000527251. PubMed PMID:36937159 PubMed Central PMC10015646.
  102. Sanchez, K, Kamal, K, Manjaly, P, Ly, S, Mostaghimi, A. Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer. Curr Treat Options Oncol. 2023;24 (4):373-379. doi: 10.1007/s11864-023-01065-4. PubMed PMID:36917395 PubMed Central PMC10011774.
  103. Gao, W, Mostaghimi, A, Gandhi, K, Done, N, Ray, M, Signorovitch, J et al.. Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States. J Med Econ. 2023;26 (1):441-444. doi: 10.1080/13696998.2023.2188843. PubMed PMID:36896625 .
  104. Mostaghimi, A, Gao, W, Ray, M, Bartolome, L, Wang, T, Carley, C et al.. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. JAMA Dermatol. 2023;159 (4):411-418. doi: 10.1001/jamadermatol.2023.0002. PubMed PMID:36857069 PubMed Central PMC9979012.
  105. Han, JJ, Manjaly, P, Lee, KJ, Kassamali, B, Kus, KJB, Pérez-Chada, LM et al.. Physician values in alopecia areata treatment decision-making: A qualitative assessment. JAAD Int. 2023;11 :14-23. doi: 10.1016/j.jdin.2022.11.010. PubMed PMID:36818678 PubMed Central PMC9932109.
  106. Ingen-Housz-Oro, S, Schmidt, V, Ameri, MM, Abe, R, Brassard, A, Mostaghimi, A et al.. Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. Orphanet J Rare Dis. 2023;18 (1):33. doi: 10.1186/s13023-023-02631-7. PubMed PMID:36814255 PubMed Central PMC9945700.
  107. Huang, K, Mostaghimi, A. Shared Decision-making, Therapeutic Choice and Decisional Regret in Alopecia Areata-Where Narrative Ethics Meets the Unconscious Bias of Clinicians-Reply. JAMA Dermatol. 2023;159 (4):462-463. doi: 10.1001/jamadermatol.2022.6533. PubMed PMID:36811904 .
  108. Manjaly, C, Martinez, J, Barbieri, J, Mostaghimi, A. Clascoterone for treatment of acne. Drugs Today (Barc). 2023;59 (2):71-81. doi: 10.1358/dot.2023.59.2.3507749. PubMed PMID:36811407 .
  109. Wang, YD, Meyer, Q, Tang, K, McClure, JE, White, RT, Kelly, ST et al.. Large-scale physically accurate modelling of real proton exchange membrane fuel cell with deep learning. Nat Commun. 2023;14 (1):745. doi: 10.1038/s41467-023-35973-8. PubMed PMID:36788206 PubMed Central PMC9929041.
  110. King, B, Mostaghimi, A, Shimomura, Y, Zlotogorski, A, Choi, GS, Blume-Peytavi, U et al.. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials. Br J Dermatol. 2023;188 (2):218-227. doi: 10.1093/bjd/ljac059. PubMed PMID:36763878 .
  111. Noe, MH, Archila, M, Barbieri, JS, Goldman, N, Lopez, CG, Mostaghimi, A et al.. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023;315 (6):1583-1592. doi: 10.1007/s00403-023-02546-0. PubMed PMID:36749390 PubMed Central PMC9904245.
  112. Pimentel, MA, Li, MM, Noe, MH, Latour, E, Seminario-Vidal, L, Greiling, T et al.. Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. Br J Dermatol. 2023;188 (4):566-568. doi: 10.1093/bjd/ljac137. PubMed PMID:36746554 PubMed Central PMC11110082.
  113. Han, JJ, Faletsky, A, Ghatnekar, S, Lee, KJ, Pérez-Chada, LM, Li, SJ et al.. Factors influencing alopecia areata treatment decisions: A qualitative assessment. JAAD Int. 2023;10 :77-83. doi: 10.1016/j.jdin.2022.10.007. PubMed PMID:36688102 PubMed Central PMC9850169.
  114. Creadore, A, Manjaly, P, Tkachenko, E, Li, DG, Kaffenberger, B, Shinkai, K et al.. The utility of augmented teledermatology to improve dermatologist diagnosis of cellulitis: a cross-sectional study. Arch Dermatol Res. 2023;315 (5):1347-1353. doi: 10.1007/s00403-022-02517-x. PubMed PMID:36580098 PubMed Central PMC9798350.
  115. Kumar, AM, Chen, ST, Merola, JF, Mostaghimi, A, Zhou, XA, Fett, N et al.. Monkeypox outbreak, vaccination, and treatment implications for the dermatologic patient: Review and interim guidance from the Medical Dermatology Society. J Am Acad Dermatol. 2023;88 (3):623-631. doi: 10.1016/j.jaad.2022.10.050. PubMed PMID:36528266 PubMed Central PMC9749826.
  116. Anand, P, Schneeweiss, S, Mostaghimi, A, Schneeweiss, MC. Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis. Pharmacoepidemiol Drug Saf. 2023;32 (5):567-576. doi: 10.1002/pds.5586. PubMed PMID:36527432 PubMed Central PMC10073264.
  117. Gandhi, K, Shy, ME, Ray, M, Fridman, M, Vaghela, S, Mostaghimi, A et al.. The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata. Dermatol Ther (Heidelb). 2023;13 (1):285-298. doi: 10.1007/s13555-022-00864-1. PubMed PMID:36484916 PubMed Central PMC9823171.
  118. Idrus-Saidi, SA, Tang, J, Lambie, S, Han, J, Mayyas, M, Ghasemian, MB et al.. Liquid metal synthesis solvents for metallic crystals. Science. 2022;378 (6624):1118-1124. doi: 10.1126/science.abm2731. PubMed PMID:36480610 .
  119. Drake, L, Reyes-Hadsall, S, Martinez, J, Heinrich, C, Huang, K, Mostaghimi, A et al.. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol. 2023;159 (1):79-86. doi: 10.1001/jamadermatol.2022.4867. PubMed PMID:36449274 .
  120. Ly, S, Kamal, K, Manjaly, P, Barbieri, JS, Mostaghimi, A. Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review. Dermatol Ther (Heidelb). 2023;13 (1):115-130. doi: 10.1007/s13555-022-00854-3. PubMed PMID:36447117 PubMed Central PMC9823189.
Search PubMed